Antibody new drugs
| Project | Indication | Hit | Lead | Lead Optimization |
Candidate | Preclinical | Phase I | Phase II | Phase III |
|---|---|---|---|---|---|---|---|---|---|
| HH101 | Solid Cancer | ||||||||
| HH102 | Solid Cancer | ||||||||
| HH103 | Solid Cancer |
Synthetic new drugs
| Project | Indication | Hit | Lead | Lead Optimization |
Candidate | Preclinical | Phase I | Phase II | Phase III |
|---|---|---|---|---|---|---|---|---|---|
| HH201 | Solid Cancer |